It Is a Long Way to GM Agriculture
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Living Being's Finished Arrangement of DNA
e in G net ts ic n E e n g m i e n c e e n r a i v n d g A ISSN: 2169-0111 Advancements in Genetic Engineering Editorial Living Being's Finished Arrangement of DNA Bahman Hosseini* Department of Horticulture, Faculty of Agriculture, Urmia University, Iran INTRODUCTION MS2 coat protein work, deciding the total nucleotide-succession of bacteriophage MS2-RNA (whose genome encodes only four Genomics is an interdisciplinary field of science zeroing in on qualities in 3569 base sets [bp]) and Simian infection 40 out of the construction, work, advancement, planning, and altering of 1976 and 1978, individually. genomes. A genome is a living being's finished arrangement of DNA, including the entirety of its qualities. Rather than Notwithstanding his fundamental work on the amino corrosive hereditary qualities, which alludes to the investigation of arrangement of insulin, Frederick Sanger and his associates individual qualities and their parts in legacy, genomics focuses assumed a vital part in the advancement of DNA sequencing on the aggregate portrayal and evaluation of the entirety of a life strategies that empowered the foundation of thorough genome form's qualities, their interrelations and effect on the creature. sequencing projects. In 1975, he and Alan Coulson distributed a Qualities may coordinate the creation of proteins with the help sequencing methodology utilizing DNA polymerase with of chemicals and courier atoms. Thusly, proteins make up body radiolabelled nucleotides that he called the Plus and Minus designs, for example, organs and tissues just as control synthetic strategy. This elaborate two firmly related strategies that created responses and convey signals between cells. -
Genome Mapping and Genomics in Animals Volume 1
Genome Mapping and Genomics in Animals Volume 1 Series Editor: Chittaranjan Kole Wayne Hunter, Chittaranjan Kole (Editors) Genome Mapping and Genomics in Arthropods With 25 Illustrations, 3 in Color 123 Way n e Hu n t e r Chittaranjan Kole USDA, ARS, United States Department of Genetics & Biochemistry Horticultural Research Laboratory Clemson University 2001 South Rock Road Clemson, SC 29634 Fort Pierce, FL 34945 USA USA e-mail: [email protected] e-mail: [email protected] ISBN 978-3-540-73832-9 e-ISBN 978-3-540-73833-6 DOI 10.1007/978-3-540-73833-6 Library of Congress Control Number: 2007934674 © Springer-Verlag Berlin Heidelberg 2008 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broad- casting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permissions for use must always be obtained from Springer. Violations are liable for prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Cover design: WMXDesign GmbH, Heidelberg, Germany Printed on acid-free paper 987654321 springer.com Preface to the Series The deciphering of the sequence of a gene for the first time, the gene for bacterio- phage MS2 coat protein to be specific, by Walter Fiers and his coworkers in 1972 marked the beginning of a new era in genetics, popularly known as the genomics era. -
Clark, Kyle.Pdf
SEQUENCING FIELD ISOLATES OF ILTV by Kyle Clark A thesis submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements for the degree of Bachelor of Science in Animal Science with Distinction. Spring 2010 Copyright 2010 Kyle Clark All Rights Reserved Sequencing Field Isolates of ILTV by Kyle Clark Approved: ________________________________________________ Calvin Keeler, Ph.D. Professor in charge of thesis on behalf of the Advisory Committee Approved: ________________________________________________ Carl Schmidt, Ph.D. Committee member from the Department of Animal and Food Sciences Approved:_________________________________________________ Nicole Donofrio, Ph.D. Committee member from the Board of Senior Thesis Readers Approved:__________________________________________________ Ismat Shah, Ph.D. Chair of the University Committee on Student and Faculty Honors ACKNOWLEDGMENTS I would like to thank Bruce Kingham for his support and sequencing assistance. I would also like to thank Cynthea Boettger for her continued assistance and instruction throughout my research. Finally, I wish to thank the University of Delaware Undergraduate Research office for their grant to further support my research. iii TABLE OF CONTENTS LIST OF TABLES ......................................................................................................... vi LIST OF FIGURES ...................................................................................................... vii ABSTRACT ............................................................................................................... -
Human Genetics 1990–2009
Portfolio Review Human Genetics 1990–2009 June 2010 Acknowledgements The Wellcome Trust would like to thank the many people who generously gave up their time to participate in this review. The project was led by Liz Allen, Michael Dunn and Claire Vaughan. Key input and support was provided by Dave Carr, Kevin Dolby, Audrey Duncanson, Katherine Littler, Suzi Morris, Annie Sanderson and Jo Scott (landscaping analysis), and Lois Reynolds and Tilli Tansey (Wellcome Trust Expert Group). We also would like to thank David Lynn for his ongoing support to the review. The views expressed in this report are those of the Wellcome Trust project team – drawing on the evidence compiled during the review. We are indebted to the independent Expert Group, who were pivotal in providing the assessments of the Wellcome Trust’s role in supporting human genetics and have informed ‘our’ speculations for the future. Finally, we would like to thank Professor Francis Collins, who provided valuable input to the development of the timelines. The Wellcome Trust is a charity registered in England and Wales, no. 210183. Contents Acknowledgements 2 Overview and key findings 4 Landmarks in human genetics 6 1. Introduction and background 8 2. Human genetics research: the global research landscape 9 2.1 Human genetics publication output: 1989–2008 10 3. Looking back: the Wellcome Trust and human genetics 14 3.1 Building research capacity and infrastructure 14 3.1.1 Wellcome Trust Sanger Institute (WTSI) 15 3.1.2 Wellcome Trust Centre for Human Genetics 15 3.1.3 Collaborations, consortia and partnerships 16 3.1.4 Research resources and data 16 3.2 Advancing knowledge and making discoveries 17 3.3 Advancing knowledge and making discoveries: within the field of human genetics 18 3.4 Advancing knowledge and making discoveries: beyond the field of human genetics – ‘ripple’ effects 19 Case studies 22 4. -
Agrobacterium Tumefaciens-Mediated Transformation of Arabidopsis
Proc. Natl. Acad. Sci. USA Vol. 85, pp. 5536-5540, August 1988 Botany Agrobacterium tumefaciens-mediated transformation of Arabidopsis thaliana root explants by using kanamycin selection (herbicide resistance/neomycin phosphotransferase II/plant regeneration/tumor-inducing Ti plasmid/transgenic plants) DIRK VALVEKENS, MARC VAN MONTAGU*, AND MIEKE VAN LIJSEBETTENS Laboratorium voor Genetica, Rijksuniversiteit Gent, B-9000 Ghent, Belgium Contributed by Marc Van Montagu, April 5, 1988 ABSTRACT Culture conditions were developed that in- (Landbouwuniversiteit Wageningen); and Arabidopsis eco- duce Arabidopsis thaliana (L.) Heynh. root cuttings to regen- type Columbia, by G. Rddei (Columbia University). erate shoots rapidly and at 100% efficiency. The shoots Agrobacterium Strains. A. tumefaciens C58ClRifR con- produce viable seeds in vitro or after rooting in soil. A taining the nononcogenic tumor-inducing Ti plasmid transformation procedure for Arabidopsis root explants based pGSFR1161 was obtained from J. Botterman (Plant Genetic on kanamycin selection was established. By using this regen- Systems, Ghent, Belgium). pGSFR1161 is a cointegrate eration procedure and an Agrobacterium tumor-inducing Ti vector between pGV2260 (11) and pGSFR161 (Fig. 1). Be- plasmid carrying a chimeric neomycin phosphotransferase II tween the borders of the transferred DNA (T-DNA; portion gene (neo), transformed seed-producing plants were obtained of the Ti plasmid that is transferred to plant cells), the with an efficiency between 20% and 80% within 3 months after construct contains a chimeric bar (13) and neo gene (from gene transfer. F1 seedlings of these transformants showed transposon TnS) under control of the T-DNA TR promoter Mendelian segregation of the kanamycin-resistance trait. The (the dual promoter from the TR-DNA of an octopine Ti transformation method could be applied to three different plasmid) (14); the neo gene encodes neomycin phosphotrans- Arabidopsis ecotypes. -
Genetically Modified Food
GENETICALLY MODIFIED FOOD: CONSUMER BEHAVIOUR TOWARDS IT AND COMMUNICATION TO IMPROVE THE CONSUMER’S PERCEPTION OF IT LIES GOETHALS Thesis Meertalige Bedrijfscommunicatie 2006-2007 Promotor : Prof. Dr. E. ROEGIEST I Beschrijving van de stage Bedrijf Stagebegeleider Afdeling VIB Ann Van Gysel Communicatie Rijvisschestraat 120 Sooike Stoops 9052 Gent tel. 09 / 244 66 11 fax. 09 / 244 66 10 www.vib.be Taakbeschrijving Talen Periode *Verwerking van een enquête rond de Nederlands 22/04/2007 tentoonstelling DE ZAAK DNA. Engels tot *Opstellen van een brochure om 01/06/2007 middelbare school-studenten aan te zetten levenswetenschappen te studeren. *Meewerken aan events zoals Scientists @work en sportdag. *Rondleidingen geven in de labo’s op Vlaanderendag. II A word of thanks to… ... my promoter Prof Dr Roegiest and, in particular, Luc De Bie. I can honestly say that without them and the liberating phone call that I got one year ago, I would never have come this far. I would also like to thank them for the help, tips and tricks concerning the theoretical part of my thesis. ... Ann Van Gysel who gave me the opportunity of doing this traineeship in a pleasant environment like VIB (Flemish Institute for Biotechnology). … Sooike Stoops who guided me during the 6 weeks of my internship, for everything she taught me, for her patience, her enthusiasm and the support she was for me. For the tips and tricks, her corrections, her chats to check if everything was alright … ... the other VIB colleagues of the communication department: Evy, Inge, Joke, Jonas and Niels for sharing their experience, for lending a helping hand, for the nice chats. -
Marc Van Montagu Mary-Dell Chilton Robert T
2013 World Food Prize Marc Van Montagu Mary-Dell Chilton Robert T. Fraley Laureates Belgium United States United States Three distinguished scientists —Marc Van Montagu of Belgium, and Mary-Dell Chilton and Robert T. Fraley of the United States — will share the 2013 World Food Prize for their independent, individual breakthrough achievements in founding, developing, and applying modern agricultural biotechnology. Their research has made it possible for farmers to grow crops with resistance to insects and disease, tolerance to herbicides, and the ability to tolerate extreme variations in climate such as excessive heat and drought.” Building upon the scientific discovery of the Double Helix structure of DNA by Watson and Crick in the 1950s, Van Montagu, Chilton, and Fraley each conducted groundbreaking molecular research on how a plant bacterium could be adapted as a tool to insert genes from another organism into plant cells, which could produce new genetic lines with highly favorable traits. And, they are credited with developing the first transgenic plants. The revolutionary biotechnology discoveries of these three individuals —each working in separate facilities on two continents—unlocked the key to plant cell transformation using recombinant DNA. Their work led to the development of a host of genetically enhanced crops that were grown on more than 170 million hectares around the globe by 17.3 million farmers in 2012. Over 90 percent of these were small resource-poor farmers in developing countries. The combined achievements of the 2013 World Food Prize Laureates, from their work in the laboratory to applying biotechnology innovations in farmers’ fields, have contributed significantly to increasing the quantity and availability of food, and can play a critical role as we face the global challenges of the 21st Century of producing more food, in a sustainable way, while confronting an increasingly volatile climate. -
DNA Sequencing Link: DNA Sequencing
DNA Sequencing link: http://en.wikipedia.org/wiki/DNA_sequencing DNA sequencing From Wikipedia, the free encyclopedia Jump to: navigation, search The term DNA sequencing encompasses biochemical methods for determining the order of the nucleotide bases, adenine, guanine, cytosine, and thymine, in a DNA oligonucleotide. The sequence of DNA constitutes the heritable genetic information in nuclei, plasmids, mitochondria, and chloroplasts that forms the basis for the developmental programs of all living organisms. Determining the DNA sequence is therefore useful in basic research studying fundamental biological processes, as well as in applied fields such as diagnostic or forensic research. The advent of DNA sequencing has significantly accelerated biological research and discovery. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the large-scale sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences of many animal, plant, and microbial genomes. DNA Sequence Trace Contents [hide] 1 Early methods 2 Maxam-Gilbert sequencing 3 Chain-termination methods o 3.1 Dye-terminator sequencing o 3.2 Challenges o 3.3 Automation and sample preparation 4 Large-scale sequencing strategies 5 New sequencing methods o 5.1 High-throughput sequencing o 5.2 Other sequencing technologies 6 Major landmarks in DNA sequencing 7 See also 8 Citations 9 External links [edit] Early methods For thirty years, a large proportion of DNA sequencing has been carried out with the chain- termination method developed by Frederick Sanger and coworkers in 1975.[1][2] Prior to the development of rapid DNA sequencing methods in the early 1970s by Sanger in England and Walter Gilbert and Allan Maxam at Harvard,[3][4] a number of laborious methods were used. -
Pharmacogenomics: the Right Drug to the Right Person
Elmer Press Review J Clin Med Res • 2009;1(4):191-194 Pharmacogenomics: The Right Drug to the Right Person Aneesh T Pa, b, Sonal Sekhar Ma, Asha Josea, Lekshmi Chandrana, Subin Mary Zachariaha is a complex trait that is influenced by many different genes. Abstract Without knowing all of the genes involved in drug response, scientists have found it difficult to develop genetic tests that Pharmacogenomics is the branch of pharmacology which could predict a person’s response to a particular drug [1]. deals with the influence of genetic variation on drug response in Once scientists discovered that people’s genes show small patients by correlating gene expression or single-nucleotide poly- variations (or changes) in their nucleotide (DNA base) con- morphisms with a drug’s efficacy or toxicity. It aims to develop tent, all of that changed: genetic testing for predicting drug rational means to optimize drug therapy, with respect to the pa- response is now possible. Pharmacogenomics combines tra- tient’s genotype, to ensure maximum efficacy with minimal ad- ditional pharmaceutical sciences such as biochemistry with verse effects. Such approaches promise the advent of ‘personalized medicine’, in which drugs and drug combinations are optimized for annotated knowledge of genes, proteins, and single nucle- each individual’s unique genetic makeup. Pharmacogenomics is the otide polymorphisms. The most common variations in the whole genome application of pharmacogenetics, which examines human genome are called single nucleotide polymorphisms the single gene interactions with drugs. (SNPs). There is estimated to be approximately 11 million SNPs in the human population, with an average of one every 1,300 base pairs. -
Transgenic Plants: from First Successes to Future Applications MIEKE VAN LIJSEBETTENS1,2,*, GEERT ANGENON3 and MARC DE BLOCK4
Int. J. Dev. Biol. 57: 461-465 (2013) doi: 10.1387/ijdb.130063mv www.intjdevbiol.com Transgenic plants: from first successes to future applications MIEKE VAN LIJSEBETTENS1,2,*, GEERT ANGENON3 and MARC DE BLOCK4 1Department of Plant Systems Biology, VIB, 9052 Gent, Belgium, 2Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Gent, Belgium, 3Institute for Molecular Biology and Biotechnology, Vrije Universiteit Brussel, 1050 Brussels, Belgium and 4Bayer CropScience NV, Innovation Center, 9052 Gent, Belgium ABSTRACT This dialogue was held between the Guest Editors of the Special Issue on “Plant Trans- genesis” of the Int. J. Dev. Biol. and Marc De Block. He was one of the first scientists worldwide to obtain transgenic plants transformed with the chimeric selectable marker genes encoding neomy- cin phosphotransferase and bialaphos that confer resistance against the antibiotic kanamycin and the herbicide Basta®/glufosinate, respectively at the Department of Genetics of Ghent University and, later on, at the spin-off company, Plant Genetic Systems. Today, these two genes are still the most frequently utilized markers in transgene technology. Marc De Block chose to work on the improvement of crops in an industrial environment to help realize the production of superior seeds or products. He was part of the team that developed the male sterility/restorer system in canola (Brassica napus var. napus) that led to the first hybrid lines to be commercialized as successful products of transgene technology. In more than 30 years of research, he developed transformation procedures for numerous crops, designed histochemical, biochemical and physiological assays to monitor plant performance, and made original and innovative contributions to plant biology. -
Marc Van Montagu - Historical Account of Achievements
MARC VAN MONTAGU - HISTORICAL ACCOUNT OF ACHIEVEMENTS Marc Van Montagu is widely recognized as a world’s leading plant biotechnologist. His international intellectual leadership and field-defining discoveries have steered the development of plant biotechnology. DISCOVERY OF TI PLASMID The celebrated discovery of the Ti-plasmid of Agrobacterium tumefaciens by Jeff Shell, Marc Van Montagu and colleagues, and their research on the natural mechanism of gene transfer from Agrobacterium to plants, resulted in ground-breaking plant molecular genetics tools that rocketed fundamental and applied knowledge in plant sciences Marc Van Montagu and Jeff Shell became interested in crown-gall-inducing strains of the bacterium Agrobacterium tumefaciens as a research model to their laboratory at Ghent University, Belgium in the late sixties. It was because the interaction between the bacteria and their hosts displayed many unusual features. Unlike other pathogenic bacteria that are known to cause plant tissues to die, wilt, or become discoloured, A. tumefaciens have the ability to cause infected plant cells to proliferate and form a tumour. Most unusually, crown gall tissues could be maintained in definitively in vitro in the absence of hormones and of Agrobacterium. This observation led, in 1947, to the concept of a tumour-inducing principle (TIP), a postulation that implied that the bacteria transferred this principle to the plant cell to induce transformation (1). Much work has ensued to identify the TIP. The preferred hypothesis in the late 60’s was that a bacteriophage would be the causing agent. Marc Van Montagu and Jeff Schell explored the possibility that bacterial DNA could be involved in Agrobacterium tumourgenesis. -
Kate Fitzgerald
In This Issue: 2019 Young Investigator Awardees pgs. 3-8 Italian COVID-19 Storms pg. 11 In Memorium pgs. 12-15 New Member Mini-Bios pgs. 17-19 Spotlight: Women in Science pgs. 21-23 Cytokines 2020 pgs. 24-27 Si g n THE INTERNATIONALa CYTOKINEl & INTERFERONs SOCIETY+ NEWSLETTER APRIL 2020 I VOLUME 8 I NO. 1 A NOTE FROM THE ICIS PRESIDENT Kate Fitzgerald I write this note as all of us reach a new norm of working “remotely”. I want to extend my sincere appreciation to all members of the ICIS community around the globe who have stepped up to meet the unique and unforeseen challenges of this time. The precautions that have been implemented at all of our institutions and companies, in accordance with local and national public health guidance, will no doubt help mitigate the spread of COVID-19. We should remain firmly committed to physical distancing to make us all safer. We stand with our Italian, Spanish and New York colleagues in particular, who are facing very difficult times right now and hope things will improve there soon. It’s hard to understate the importance of the scientific enterprise and the work we as cytokine and interferon biologists do in light of the COVID-19 pandemic. Our past and current efforts to understand the host response to viruses and other pathogens and the importance of IFN and cytokines in controlling infection and the immune response to vaccines could not be more important than it is now. Understanding cytokine and interferon biology is fundamental to human health and disease.